As of 2024-12-15, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.9x - 19.8x | 6.4x |
| Forward P/E multiples | 8.2x - 11.4x | 11.4x |
| Fair Price | (14.02) - (19.82) | (15.32) |
| Upside | -1010.3% - -1387.1% | -1094.6% |
| Date | EV/EBITDA |